Merck & Co., Inc. Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year
Merck & Co., Inc. (MRK) had Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year of $220.00 million as of 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Notes › Compensation Related Costs › Defined Benefit Plan
us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear · last filed 2020-08-05
- 2020-06-30: Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year $220.00M.
| Period end | Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year |
|---|---|
| 2020-06-30 | $220.00M 10-Q · filed 2020-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |